NSAIDs & ulcers
This article was originally published in The Tan Sheet
Executive Summary
Peptic ulcers are "significantly more common in H. pylori infected NSAID takers than in takers without the infection, suggesting a possible interaction," Canadian researchers report in Jan. 5 Lancet. In a meta-analysis, Jia-Qing Huang, et al., McMaster University Medical Center, identified 16 studies with data on H. pylori status for 1,625 NSAID users. "In five controlled studies, peptic ulcer disease was significantly more common in NSAID takers (35.8%) than in controls (8.3%) irrespective of H. pylori infection. Compared with H. pylori negative individuals not taking NSAIDs, the risk of ulcer in H. pylori infected NSAID takers was 61.1," researchers say...
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.